EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Association of Primary Tumor Resection with Survival in De Novo Stage IV Colorectal Cancer: A Retrospective Cohort Study with Propensity Score Matching

Hatice Ayyıldız Sevim iD, Galip Can Uyar iD, Hayriye Şahinli iD

Current Oncology · 05.08.2026 · 33 (8) · 467

DOI: 10.3390/curroncol33080467 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Current Oncology, online erschienen am 05.08.2026. Verfasst von Hatice Ayyıldız Sevim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Türkiye. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The role of primary tumor resection (PTR) in patients with de novo stage IV colorectal cancer remains controversial, particularly in the context of patient selection and tumor biology. This study aimed to evaluate the association between PTR and survival outcomes and to identify clinical, molecular, and inflammatory-nutritional prognostic factors in patients with de novo stage IV colorectal cancer.

Methods

Medical records of 204 patients with de novo stage IV colorectal adenocarcinoma treated at Ankara Etlik City Hospital from December 2022 to December 2025 were reviewed retrospectively. Patients were grouped according to PTR status. Baseline clinicopathological features, molecular tumor profile, metastatic disease extent, treatment characteristics, and inflammatory-nutritional markers were recorded. Survival outcomes were assessed in terms of progression-free survival (PFS) and overall survival (OS) using the Kaplan–Meier method and Cox proportional hazards regression models, as well as 1:1 propensity score matching and sensitivity analyses.

Results

PTR was performed in 114 patients (55.9%), while 90 patients (44.1%) did not undergo PTR. Patients who underwent PTR were younger, had better Eastern Cooperative Oncology Group (ECOG) performance status, and more frequently had single-organ metastatic disease. In the unmatched cohort, patients who underwent PTR had longer median PFS and OS than those without PTR (15.88 vs. 11.03 months and 16.14 vs. 11.54 months, respectively; both log-rank p < 0.001). In the adjusted Cox models, PTR corresponded to lower risks of progression (hazard ratio [HR]: 0.50; 95% confidence interval [CI]: 0.34–0.74; p < 0.001) and death (HR: 0.48; 95% CI: 0.30–0.77; p = 0.002), whereas BRAF mutation showed higher risks of progression (HR: 3.00; 95% CI: 1.70–5.29; p < 0.001) and death (HR: 3.42; 95% CI: 1.83–6.38; p < 0.001). In the propensity score–matched cohort comprising 50 matched pairs, PTR remained associated with a lower risk of progression or death (HR: 0.59; 95% CI: 0.40–0.87; p = 0.007), whereas its association with OS was not statistically significant (HR: 0.69; 95% CI: 0.42–1.13; p = 0.141). Sensitivity analyses generally yielded estimates favoring PTR, although the statistical significance of the association with OS varied across analyses. Patients with higher prognostic nutritional index (PNI) values showed more favorable survival outcomes.

Conclusions

In this retrospective cohort, PTR was consistently associated with longer PFS, whereas its association with OS was less robust across the adjusted analyses. Because these patients had a more favorable baseline profile, these associations should be viewed with caution and in relation to patient selection. BRAF mutation and PNI emerged as important prognostic factors, supporting a multidimensional approach to survival assessment that incorporates metastatic disease burden, tumor biology, and inflammatory-nutritional status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsHumansRetrospective StudiesFemaleMaleNeoplasm StagingPropensity ScoreAgedMiddle AgedPrognosis

Stichwörter der Autor:innen

colorectal cancerde novo stage IVoverall survivalprimary tumor resectionprogression-free survival

Autor:innen und Institutionen

  • Department of Medical Oncology, Ankara Etlik City Hospital, Ankara 06170, Türkiye.

ORCID-Profile: Hatice Ayyıldız Sevim, Galip Can Uyar, Hayriye Şahinli

Zitieren

APA

Ayyıldız Sevim, H., Uyar, G. C., & Şahinli, H. (2026). Association of Primary Tumor Resection with Survival in De Novo Stage IV Colorectal Cancer: A Retrospective Cohort Study with Propensity Score Matching. Current Oncology, 33(8), 467. https://doi.org/10.3390/curroncol33080467

Vancouver

Ayyıldız Sevim H, Uyar GC, Şahinli H. Association of Primary Tumor Resection with Survival in De Novo Stage IV Colorectal Cancer: A Retrospective Cohort Study with Propensity Score Matching. Current Oncology. 2026;33(8):467. doi:10.3390/curroncol33080467

BibTeX
@article{AyyldzSevim2026,
  author = {Ayyıldız Sevim, Hatice and Uyar, Galip Can and Şahinli, Hayriye},
  title = {Association of Primary Tumor Resection with Survival in De Novo Stage IV Colorectal Cancer: A Retrospective Cohort Study with Propensity Score Matching},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {8},
  pages = {467},
  doi = {10.3390/curroncol33080467}
}
Kostenlos starten →